+1 (202) 282-5415
Steve Harris is a partner in the firm’s Washington, D.C. and New York offices and concentrates his practice in antitrust/competition law, including litigation, cartel defense, merger control filings, and administrative proceedings before U.S. and international courts and agencies. He has particular experience working with clients in China, Korea, Japan, and Taiwan.
Mr. Harris’ representative matters include:
Represented a major U.S. consumer products company in antitrust cartel investigation and follow-on class action litigation.
Represented a European chemicals manufacturer in antitrust cartel investigation in the United States and EU, and in follow-on class action litigation.
Represented a leading personal computer manufacturer in an antitrust and patent infringement action involving MPEG data compression technology.
Represented a major international airline before antitrust and regulatory agencies in Asia and the United States in a successful global effort to retain its multi-year joint business agreement with one of Asia Pacific’s leading airlines.
Represented a leading U.S. biotechnology company in worldwide antitrust and merger control issues related to USD500 million acquisition by European multinational crop science company.
This matter was granted early termination by the U.S. Department of Justice Antitrust Division.
Represented Prestige Brands Holdings Inc. in the worldwide antitrust and merger control issues related to its USD660 million acquisition of the over-the-counter pharmaceutical brands business of GlaxoSmithKline, Prestige's largest acquisition ever. The matter involved two transactions and interesting issues under the U.S. Federal Trade Commission's aggregation rule; the FTC granted early termination.
Represented a leading global information services company in worldwide antitrust and merger control proceedings; the merger presented several unusual competition law issues, including the application of the “media merger” rules in Germany and Austria.
Represented a leading specialty minerals company based in France in the U.S. antitrust and merger control issues related to its USD665 million acquisition of a talc business.
Represented a leading global medical technology company in the worldwide antitrust and merger control proceedings in its acquisition of a Swedish company involving issues related to complementary versus competitive products in several jurisdictions.
Represented a leading multinational resources company in the review of a joint venture with another large resources company under the China Anti-Monopoly Law.
Mr. Harris received his A.B., magna cum laude, from Cornell University in 1977. He received his J.D. from Columbia Law School in 1982, where he was certified with honors by the Parker Program in Foreign and Comparative Law, and was a Harlan Fiske Stone Scholar.
HONORS & AWARDS
Mr. Harris is globally recognized as a leading antitrust lawyer by publications including Chambers USA (2004-2014), International Who's Who of Competition Lawyers (2000-2013), International Who's Who of Business Lawyers (2012-2013), Best Lawyers in America (2013), Washington DC SuperLawyers (2004-2014), and Baltimore & Washington DC's Top Lawyers (2013). He was also listed in Chambers Global (2014) under Antitrust/Competition - USA and China and (2013) under Antitrust (International Law Firms) Antitrust/International as being experienced handling matters across a range of Asian jurisdictions, in particular on Chinese antitrust law issues. Mr Harris was also listed as one of the experts under Competition and Antitrust in Expert Guides, which is a legal media guide to the world's leading lawyers, chosen by their peers.
Mr. Harris is an active member of the American Bar Association – Section of Antitrust Law; he currently serves as a member of the International Task Force, and was formerly the Section’s International Officer and member of the governing Council. Currently, he is chair, Competition Law Committee of the Inter-Pacific Bar Association; former chair and current member, Mid-Atlantic Regional Board of the U.S. Fund for UNICEF, and former chair and member of the Southeastern Regional Board of the U.S. Fund for UNICEF; member, Antitrust & Competition Section of the International Bar Association; Life Fellow, American Bar Foundation; a non-governmental advisor to the International Competition Network (Unilateral Conduct Working Group) appointed by the U.S. Federal Trade Commission; member, Advisory Board of the Antitrust & Trade Reg. Report (Bloomberg BNA); member, Competition Committee of the United States Council for International Business; and member, Antitrust Council and International Competition Policy Working Group of the U.S. Chamber of Commerce.
•Author, “Due Process and Procedural Rights Under the China Anti-Monopoly Law,” CPI Antitrust Chronicle, June 2014.
•Co-author, “Anti-Monopoly Law and Practice in China,” Oxford University Press, 2011.
•Co-author, “Intellectual Property, Competition Law and Economics in Asia,” Hart Publishing, 2011.
•Co-author, Japan and Korea chapters, “Global Handbook of Antitrust and Competition Law,” Oxford University, D. Sokol, D. Crane, and A. Ezrachi eds. 2014, 2014.
•Co-author (with R. Ian McEwin), “Is East Asian Antitrust Different?,” 4 International Antitrust Bulletin 18, ABA Section of Antitrust Law, December 2012.
•Co-author, “Outbound China M&A and Investment – US,” China Outbound Investment Guide 2012, China Law & Practice, Spring 2012.
•Co-author (with John Fedele), “The Danger of ‘Fairness’: Section 5 of the FTC Act and the Propagation of the ‘Unfairness’ Standards,” chapter in William E. Kovacic, An Antitrust Amicorum, Vol. 1, Institute of Competition Law, 2012.
•Co-author, “The Doctrine of ‘Unfairness’ and its Effect on Global Competition Policy,” Concurrences, publication forthcoming.
•Co-author, competition law chapter, Corporate Counsel’s Guide to Doing Business in China, 4th edition, 2012, and previous editions.
•Co-author, “The Monopolization and IP Abuse Provisions of China’s Anti-Monopoly Law: Concerns and a Proposal,” 75 Antitrust L.J. 1, 2008.
•Author, “The Making of an Antitrust Law: The Pending Anti-Monopoly Law of the People's Republic of China,” 7 Chi. J. Intl. L. 169, 2006.
•Author, “Competition Law and Patent Protection in Japan: A Half-Century of Progress, A New Millennium of Challenges,” 16 Colum. J. Asia L. 71, 2002.
•Speaker, China Anti-Monopoly Law Enforcement Rountable, The Brookings Institution, 19 May 2015
•Speaker, “Competition Issues Arising from International Trade and Labour Disputes;” “Competition Investigations in Asia: A Rising Tide;” “What Does FRAND Mean?” Inter-Pacific Bar Association Annual Meeting, Hong Kong, 5 May 2015
•Speaker, Panel addressing China Antitrust and IP Developments, U.S. Chamber of Commerce, 17 April 2015
•Speaker, “Antitrust and IP in China, Quo Vadis?” ABA Section of Antitrust Law Spring Meeting, 16 April 2015
•Speaker, “Due Process Issues in India and China,” USCIB Competition Committee Meeting, 14 April 2015
•Speaker, “NDRC's Qualcomm Decision and Beyond – New Developments in China's Antitrust & IP Enforcement,” ABA Section of International Law, 26 March 2015
•Panelist, “Economics and Economic Evidence across Regimes,” George Mason Law Review 18th Annual Antitrust Symposium: Perspectives on Global Competition Law, 19 February 2015
•Speaker, “Antitrust Update for In-House Counsel,” ABA Corporate Counseling Committee, 8 December 2014
•Speaker, “Cartels & Other Concerted Practices: Proof, Evidence, Presumptions, Enforcement,” – Antitrust in Emerging and Developing Countries featuring China, India, Mexico, Brazil, South Africa – NYU School of Law and Concurrences Competition Law Journal Conference, 24 October 2014
•Speaker, “Transborder Vertical Restrictions in IP Licenses: Convergence or Divergence?” – ABA International Section – ABA 2015 Spring Meeting, 29 April 2015
•Speaker, “Antitrust Enforcement in China – What's Next?” – GCR Live seminar, New York, 17 September 2014
•Speaker, 26th All Hands Meeting, 7 November 2014
•Speaker, The Concurrences/NYU conference, 24 October 2013
•Speaker, The Knowledge Group webinar, 9 September 2014
•Speaker, Inter Pacific Bar Association Mid-Year Council Meeting and Regional Conference – cartels seminar – Brazil, 26 September 2014
•Speaker, the American Bar Association program on the SAIC's 8th Draft AML/IP Rules, 26 August 2014
•Chair, Oxford Union-style debate on the motion “This house believes the pendulum of enforcement in the U.S. and EU has swung too far towards non-intervention,” GCR Live, New York City, 17 September 2013.
•Keynote Speaker and Panelist, “The Relationship Between Intellectual Property Law and Antitrust,” China Competition Policy Forum –Transformation of Competition Policy, hosted by the Expert Advisory Board of the State Council Anti-Monopoly Commission of the People’s Republic of China, Beijing, 31 July-1 August 2013.
•Moderator, “New Developments in Merger Remedies in China,” ABA Section of Antitrust Law International Committee and ABA Section of International Law, International Antitrust Law Committee, July 2013.
•Moderator, “Interaction of IP and Antitrust: a US-China Comparative Perspective,” George Washington University Law School, Washington, D.C., June 2013.
•Moderator, “Update on Antitrust Enforcement in India,” and Speaker, “Antitrust Issues in Doing Business in China,” The Fourth Annual Chicago Forum on International Antitrust Issues, Northwestern University School of Law, Chicago, 2013.
•Speaker, “The IP Climates in China and the United States: What Investors Need to Know,” Joint US Chamber of Commerce-China Council for the Promotion of International Trade event, Washington, D.C., 2013.
•Moderator, “Cartel Issues on the Pacific Rim,” and Speaker, “Investment Review Issues on the Pacific Rim: Inbound Investments in Australia, the U.S., and Canada, and Outbound Investments from China,” IPBA 2013 Seoul Conference, Korea, 2013.
•Speaker, “Recent Developments in Antitrust Law in Asia,” Global Competition Review Live: 2nd Annual Law Leaders Asia-Pacific Conference, Singapore, 2013.
•Chair, “China’s Patent Regime and Its Quest to Become an Innovation Economy,” Joint GW-Fordham Conference, Washington, D.C., 2013.
•Speaker on “Merger Remedies” to leadership and staff of Anti-Monopoly Bureau of Ministry of Commerce (MOFCOM), with representatives of the U.S. Department of Justice Antitrust Division and the U.S. Federal Trade Commission, Gaifeng, China, April 2012.